Geron Corp
NASDAQ:GERN
$1.42
$0.03
(2.16%)
Related Resources
GERN
vs. S&P 500
|
$1.42
$0.03
(2.16%)
|
|
| Today's Open | $1.39 |
|---|---|
| Previous Close | $1.39 |
| Daily Range | $1.38 - $1.44 |
| 52-Week Range | $1.35 - $4.50 |
| Market Cap | $187.6M |
| P/E Ratio | -1.90 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 369,563 |
| Average Daily Volume | 610,450 |
| Current FY EPS | -$0.60 |
Sector
Healthcare
Industry
Biotechnology
Description
A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.
